...
首页> 外文期刊>BMC Public Health >Prevention of recurrent sickness absence among employees with common mental disorders: design of a cluster-randomised controlled trial with cost-benefit and effectiveness evaluation
【24h】

Prevention of recurrent sickness absence among employees with common mental disorders: design of a cluster-randomised controlled trial with cost-benefit and effectiveness evaluation

机译:预防患有常见精神障碍的员工反复发作的疾病:采用成本效益和有效性评估的集群随机对照试验设计

获取原文
           

摘要

Background Common mental disorders, such as depression, anxiety disorder, and adjustment disorder, have emerged as a major public and occupational health problem in many countries. These disorders can have severe consequences such as absenteeism and work disability. Different interventions have been developed to improve the return-to-work of employees with common mental disorders, but still a large proportion of employees experiences health and work problems after their return-to-work. For this reason, the SHARP-at work intervention is developed to prevent a relapse of sickness absence among employees who have returned to work after a period of sickness absence because of common mental disorders. We aim to evaluate the effectiveness, cost-benefit and process of the intervention compared to care as usual. Methods/Design The study is designed as a cluster-randomised controlled trial with randomisation at the level of the occupational physician. Employees who have returned to work after a period of sickness absence because of a common mental disorder are included in the study. Employees in the intervention group will receive the SHARP-at work intervention. The intervention focusses on active guidance of employees by occupational physicians during the first weeks of work after sickness absence. Employees in the control group will receive care as usual. Outcomes will be assessed at baseline and at 3, 6, and 12 months follow-up. The primary outcome is cumulative recurrent sickness absence days. Secondary outcome measures are mental health, work functioning, and coping. Adherence to the protocol, communication between stakeholders, and satisfaction with the treatment are the process measures assessed in both study groups. Cost-benefit is calculated from a societal perspective. Finally, prognostic factors for a relapse of sickness absence are investigated. Discussion This study goes beyond return-to-work by focussing on the prevention of recurrent sickness absence. The study incorporates not only outcomes on sickness absence and mental health but also on health-related work functioning. The results of this study can contribute to a further development of practice guidelines and the promotion of sustainable work participation. Trial registration NTR1963
机译:背景技术常见的精神障碍,例如抑郁症,焦虑症和适应障碍,已成为许多国家的主要公共和职业健康问题。这些疾病可能会导致严重后果,例如旷工和工作残疾。已经开发了各种干预措施来改善患有常见精神障碍的员工的重返工作岗位,但是仍然有很大一部分员工在重返工作岗位后会遇到健康和工作问题。因此,开发SHARP-at工作干预措施是为了防止由于常见的精神障碍而在一段时间的病假后重返工作岗位的员工再次出现病假。与常规照护相比,我们旨在评估干预的有效性,成本效益和过程。方法/设计本研究被设计为一项随机分组的随机对照试验,在职业医师一级进行随机分组。由于常见的精神障碍而在一段时间的病假后重返工作岗位的员工也包括在研究中。干预组中的员工将接受SHARP-at工作干预。干预措施的重点是在病假后的头几周内,由职业医生对员工进行积极的指导。对照组的员工将照常接受护理。将在基线以及3、6和12个月的随访中评估结果。主要结局是累积的反复发作缺勤天数。次要结果指标是心理健康,工作运作和应对。遵守方案,利益相关者之间的沟通以及对治疗的满意度是两个研究小组评估的过程措施。成本效益是从社会角度计算的。最后,研究了疾病复发的预后因素。讨论本研究侧重于预防反复发作的疾病,这超出了重返工作的范围。该研究不仅纳入了疾病缺席和精神健康方面的结果,而且还纳入了与健康有关的工作功能。这项研究的结果可有助于进一步制定实践准则并促进可持续工作的参与。试用注册号NTR1963

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号